Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

103.00p
   
  • Change Today:
      2.60p
  • 52 Week High: 110.00p
  • 52 Week Low: 75.00p
  • Currency: UK Pounds
  • Shares Issued: 538.04m
  • Volume: 864,074
  • Market Cap: 554.19m
  • RiskGrade: 119
  • Beta: 0.20
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 167.30 37.30 5.60p 18.4 2.5 +8% 1.65p 1.6%
31-Dec-22 183.90 43.40 6.38p 16.1 1.2 +14% 1.67p 1.6%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2021 167 167 n/a n/a n/a n/a
31-Dec-2022 184 184 n/a n/a n/a n/a
 
Earnings
31-Dec-2021 5.60p 5.60p n/a n/a n/a n/a
31-Dec-2022 6.38p 6.38p n/a n/a n/a n/a
 
Dividend
31-Dec-2021 1.65p 1.65p n/a n/a n/a n/a
31-Dec-2022 1.67p 1.67p n/a n/a n/a n/a
 
Recommendations
Strong Buy 3 3 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 3 3 0 0 0 0
 
Average Rec 10.00 10.00 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Alliance Pharma Market Data

Currency UK Pounds
Share Price 103.00p
Change Today 2.60p
% Change 2.59 %
52 Week High 110.00p
52 Week Low 75.00p
Volume 864,074
Shares Issued 538.04m
Market Cap 554.19m
Beta 0.20
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average85.8% below the market average
28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average28.00% above the sector average
Price Trend
59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average59.50% above the market average
30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average30.00% above the sector average
Income
50% below the market average50% below the market average50% below the market average50% below the market average50% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Growth
13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average13.07% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 03-Dec-2021

Time Volume / Share Price
16:37 150,000 @ 102.43p
16:37 150,000 @ 102.43p
16:40 16,675 @ 102.43p
16:35 156,651 @ 103.00p
16:29 18 @ 101.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page